Shukra Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 6.50 | 14.74 | 11.59 |
| Operating Expense | 4.07 | 5.95 | 6.65 |
| Net Profit | 1.03 | 5.39 | 3.16 |
| Net Profit Margin | 15.85 | 36.57 | 27.26 |
| Earning Per Share | 0.02 | 0.12 | 0.72 |
| EBIDTA | 2.50 | 8.78 | 4.90 |
| Effective Tax Rate | 16.87 | 24.83 | 18.02 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 6.50 |
| Operating Expense | 4.07 |
| Net Profit | 1.03 |
| Net Profit Margin | 15.85 |
| Earning Per Share | 0.02 |
| EBIDTA | 2.50 |
| Effective Tax Rate | 16.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 32.59 | 74.57 | 58.83 |
| Operating Expenses Annual | 19.86 | 55.17 | 53.47 |
| Operating Profit Annual | 16.94 | 22.22 | 6.56 |
| Interest Annual | 0.59 | 0.29 | 0.28 |
| Depreciation | 3.00 | 2.05 | 1.84 |
| Net Profit Annual | 9.58 | 18.54 | 4.41 |
| Tax Annual | 3.76 | 1.35 | 0.04 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 32.59 |
| Operating Expenses Annual | 19.86 |
| Operating Profit Annual | 16.94 |
| Interest Annual | 0.59 |
| Depreciation | 3.00 |
| Net Profit Annual | 9.58 |
| Tax Annual | 3.76 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 9.98 | 3.97 | 0.29 |
| Cash Flow from Operations | 7.92 | -5.20 | 3.17 |
| Cash Flow from Investing | -1.26 | -1.20 | -4.43 |
| Cash Flow from Financing | -4.52 | 12.41 | 4.94 |
| Cash Flow at the End | 12.12 | 9.98 | 3.97 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 9.98 |
| Cash Flow from Operations | 7.92 |
| Cash Flow from Investing | -1.26 |
| Cash Flow from Financing | -4.52 |
| Cash Flow at the End | 12.12 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 51.95 | 29.80 | 11.15 |
| PBIT Margin (%) | 42.74 | 27.05 | 8.02 |
| PBT Margin (%) | -29.71 | -66.27 | -20.69 |
| Net PROFIT Margin (%) | 29.40 | 24.86 | 7.50 |
| Return On Networth / Equity (%) | 15.90 | 44.71 | 21.18 |
| Return On Networth /Employed (%) | 21.76 | 44.16 | 18.84 |
| Return On Assets (%) | 14.99 | 40.53 | 17.54 |
| Total Debt / Equity (X) | 0.06 | 0.10 | 0.20 |
| Asset Turnover Ratio (%) | 0.51 | 1.63 | 2.34 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 51.95 |
| PBIT Margin (%) | 42.74 |
| PBT Margin (%) | -29.71 |
| Net PROFIT Margin (%) | 29.40 |
| Return On Networth / Equity (%) | 15.90 |
| Return On Networth /Employed (%) | 21.76 |
| Return On Assets (%) | 14.99 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 0.51 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 19.40 | 19.94 | 20.23 |
| Total Current Assets Annual | 65.43 | 56.23 | 53.07 |
| Non Current Assets Annual | 21.34 | 21.60 | 21.89 |
| Total Shareholders Funds Annual | 62.84 | 57.64 | 25.30 |
| Total Assets Annual | 86.77 | 77.84 | 74.97 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 19.40 |
| Total Current Assets Annual | 65.43 |
| Non Current Assets Annual | 21.34 |
| Total Shareholders Funds Annual | 62.84 |
| Total Assets Annual | 86.77 |
No Data Availabe
